1. Barenfanger J., Drake, C., Kacich G. (1999). Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol., 37: 1415–1418.
2. Bascomb S., Godsey J.H., Kangas M., Nea L., Tomfohrde K.M. (1991). Rapid antimicrobial susceptibility testing of Grampositive cocci using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A. Pathol. Biol., 39: 466–470.
3. CLSI-Clinical and Laboratory Standards Institute (formerly the NCCLS) (2005): Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement: M100-S15. CLSI. Wayne, PA, USA.
4. Doern G., Vautour R., Gaudet M., Levy B. (1994). Clinical impact of rapidin vitro susceptibility testing and bacterial identification. J. Clin. Microbiol., 32: 1757–1762.
5. Godsey J.H., Bascomb S., Bonnette T., Kangas M., Link K., Richards K., Tomfohrde K.M. (1991). Rapid antimicrobial susceptibility testing of Gram-negative bacilli using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A. Pathol. Biol., 39: 461–465.